N. Scott Fine
Net Worth
Last updated:
What is N. Scott Fine net worth?
The estimated net worth of Mr. N. Scott Fine is at least $2,683,324 as of 20 Oct 2023. He owns shares worth $237,324 as insider and has received compensation worth at least $2,446,000 in Cyclo Therapeutics, Inc..
What is the salary of N. Scott Fine?
Mr. N. Scott Fine salary is $489,200 per year as Chief Executive Officer & Director in Cyclo Therapeutics, Inc..
How old is N. Scott Fine?
Mr. N. Scott Fine is 68 years old, born in 1957.
What stocks does N. Scott Fine currently own?
As insider, Mr. N. Scott Fine owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cyclo Therapeutics, Inc. (CYTH) | Chief Executive Officer & Director | 329,342 | $0.72 | $237,324 |
What does Cyclo Therapeutics, Inc. do?
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
N. Scott Fine insider trading
Cyclo Therapeutics, Inc.
Cyclo Therapeutics key executives
Cyclo Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Jeffrey L. Tate (67) Chief Operating Officer, Chief Quality Officer & Director
- Dr. Sharon H. Hrynkow Ph.D. (65) Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Senior Vice President of Medical Affairs
- Mr. N. Scott Fine (68) Chief Executive Officer & Director